Identification of predictive pretreatment biomarkers for neoadjuvant chemotherapy response in Latino invasive breast cancer patients
This study underscores the need to identify specific gene expression profiles and immune cell population changes to predict NAC responses, paving the way for personalized and effective treatments for the Colombian BC population.
Authors
- Jovanny Zabaleta (ORCID: https://orcid.org/0000-0002-5961-6761)
- Jone Garai
- Rafael Parra‐Medina (ORCID: https://orcid.org/0000-0002-8428-5837)
- Alba Lucía Cómbita (ORCID: https://orcid.org/0000-0001-6295-7316)
- Sandra Díaz (ORCID: https://orcid.org/0000-0002-6359-1632)
- Carlos A. Orozco (ORCID: https://orcid.org/0000-0002-7256-0942)
- Hedda Michelle Guevara-Nieto (ORCID: https://orcid.org/0000-0002-5618-6057)
- Liliana López-Kleine (ORCID: https://orcid.org/0000-0001-9325-9529)
Institutions
- Universidad Nacional de Colombia (CO)
- Instituto Nacional de Cancerología (CO)
- Fundación Universitaria de Ciencias de la Salud (CO)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- Molecular Medicine
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1186/s10020-025-01338-8
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Association for Cancer Research
- Louisiana State University
- Instituto Nacional de Cancerología
- National Institutes of Health